Tag Archives: Vertex Pharmaceuticals

November, 2018

October, 2018

August, 2018

April, 2018

December, 2017

August, 2017

July, 2017

  • 19 July

    Vertex Announces Positive Results for Cystic Fibrosis Triple Combos

    BOSTON–(BUSINESS WIRE)–Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced positive data from Phase 1 and Phase 2 studies of three different triple combination regimens in people with cystic fibrosis (CF) who have one F508del mutation and one minimal function mutation (F508del/Min). These are the first data to demonstrate the potential to treat the underlying …